Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Ann Nutr Metab ; 78(4): 213-221, 2022.
Article in English | MEDLINE | ID: mdl-35443241

ABSTRACT

INTRODUCTION: Childhood obesity is a significant and growing problem worldwide. Recent evidence suggests Follistatin-like 1 (FSTL1) and family with sequence similarity to 19 member A5 (FAM19A5) to be novel adipokines. However, very few studies have examined the plasma levels of FSTL1 and FAM19A5 in children. Therefore, this cross-sectional study evaluated the association between serum FSTL1 and FAM19A5 levels and obesity in children and investigated the relationship between FSTL1 and FAM19A5 and glucose metabolism or endothelial injury. METHODS: Fifty-five obese children and 48 healthy controls were recruited. Plasma FSTL1 and FAM19A5 levels were detected using ELISA. In addition, the association between the clinical data and anthropometric parameters was analyzed. RESULTS: Serum FAM19A5 levels were significantly decreased in the obese children, at 189.39 ± 19.10 pg/mL, compared with those without obesity, at 211.08 ± 38.09 pg/mL. Serum concentrations of FSTL1 were also significantly lower in the obese children, at 0.64 (0.37-0.64) ng/mL, compared with those without obesity, at 1.35 (1.05-2.12) ng/mL. In addition, FAM19A5 (OR = 0.943; p = 0.003) was a predictor of insulin resistance in obese children compared with healthy controls. Lastly, serum FAM19A5 and FSTL1 played mediating roles in insulin resistance in children. CONCLUSION: The serum levels of FAM19A5 and FSTL1 were decreased in obese children; therefore, FAM19A5 and FSTL1 likely play important roles in glucose metabolism in obese children.


Subject(s)
Follistatin-Related Proteins , Insulin Resistance , Pediatric Obesity , Child , Cross-Sectional Studies , Follistatin , Follistatin-Related Proteins/analysis , Follistatin-Related Proteins/metabolism , Glucose , Humans
2.
J Clin Endocrinol Metab ; 105(3)2020 03 01.
Article in English | MEDLINE | ID: mdl-31690932

ABSTRACT

AIMS: To investigate circulating levels and liver gene expression of 3 hormonal pathways associated with obesity, insulin resistance, and inflammation to identify leads towards potential diagnostic markers and therapeutic targets in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: We compared circulating levels of (1) proglucagon-derived hormones (glucagon-like peptide [GLP]-1, GLP-2, glicentin, oxyntomodulin, glucagon, major proglucagon fragment [MPGF]), (2) follistatins-activins (follistatin-like [FSTL]3, activin B), (3) IGF axis (insulin-like growth factor [IGF]-1, total and intact IGF binding protein [IGFBP]-3 and IGFBP-4, and pregnancy-associated plasma protein [PAPP]-A) in 2 studies: (1) 18 individuals with early stage NAFLD versus 14 controls (study 1; early NAFLD study) and in (2) 31 individuals with biopsy proven NAFLD (15 with simple steatosis [SS] and 16 with nonalcoholic steatohepatitis [NASH]), vs 50 controls (24 lean and 26 obese) (study 2). Liver gene expression was assessed in 22 subjects (12 controls, 5 NASH, 5 NASH-related cirrhosis). RESULTS: Patients in early stages of NAFLD demonstrate higher fasting MPGF and lower incremental increase of glicentin during oral glucose tolerance test than controls. In more advanced stages, FSTL3 levels are higher in NASH than simple steatosis and, within NAFLD patients, in those with more severe lobular and portal inflammation. The IGF-1/intact IGFBP-3 ratio is lower in patients with liver fibrosis. Genes encoding follistatin, activin A, activin B, and the IGF-1 receptor are higher in NASH. CONCLUSION: MPGF and glicentin may be involved in early stages of NAFLD, whereas FSTL3 and IGF-1/intact IGFBP3 in the progression to NASH and liver fibrosis respectively, suggesting potential as diagnostic markers or therapeutic targets.


Subject(s)
Non-alcoholic Fatty Liver Disease/diagnosis , Obesity/metabolism , Proglucagon/analysis , Severity of Illness Index , Somatomedins/analysis , Adult , Biomarkers/analysis , Biopsy , Case-Control Studies , Disease Progression , Female , Follistatin-Related Proteins/analysis , Glicentin/analysis , Glucose Tolerance Test , Humans , Insulin-Like Growth Factor Binding Protein 3/analysis , Insulin-Like Growth Factor I/analysis , Liver/metabolism , Liver Cirrhosis/etiology , Male , Middle Aged , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/metabolism , Obesity/complications
3.
Adv Protein Chem Struct Biol ; 108: 227-256, 2017.
Article in English | MEDLINE | ID: mdl-28427562

ABSTRACT

Almost 30 years ago, the protein, atrial natriuretic peptide, was identified as a heart-secreted hormone that provides a peripheral signal from the myocardium that communicates to the rest of the organism to modify blood pressure and volume under conditions of heart failure. Since then, additional peripheral factors secreted by the heart, termed cardiokines, have been identified and shown to coordinate this interorgan cross talk. In addition to this interorgan communication, cardiokines also act in an autocrine/paracrine manner to play a role in intercellular communication within the myocardium. This review focuses on the roles of newly emerging cardiokines that are mainly increased in stress-induced cardiac diseases. The potential of these cardiokines as clinical biomarkers for diagnosis and prognosis of cardiac disorders is also discussed.


Subject(s)
Heart Diseases/immunology , Inflammation/immunology , Myocardium/immunology , Activins/analysis , Activins/immunology , Animals , Biomarkers/analysis , Fibroblast Growth Factors/analysis , Fibroblast Growth Factors/immunology , Follistatin/analysis , Follistatin/immunology , Follistatin-Related Proteins/analysis , Follistatin-Related Proteins/immunology , Growth Differentiation Factor 15/analysis , Growth Differentiation Factor 15/immunology , Heart Diseases/complications , Heart Diseases/pathology , Humans , Inflammation/complications , Inflammation/pathology , Interleukin-33/analysis , Interleukin-33/immunology , Myocardium/pathology , Myostatin/analysis , Myostatin/immunology , Paracrine Communication , Stress, Physiological , Transforming Growth Factor beta/analysis , Transforming Growth Factor beta/immunology
4.
Mediators Inflamm ; 2013: 752519, 2013.
Article in English | MEDLINE | ID: mdl-24347831

ABSTRACT

Obesity is associated with a state of chronic low-grade inflammation, which contributes to insulin resistance and type 2 diabetes. However, the molecular mechanisms that link obesity to inflammation are not fully understood. Follistatin-like 1 (FSTL1) is a novel proinflammatory cytokine that is expressed in adipose tissue and secreted by preadipocytes/adipocytes. We aimed to test whether FSTL1 could have a role in obesity-induced inflammation and insulin resistance. It was found that FSTL1 expression was markedly decreased during differentiation of 3T3-L1 preadipocytes but reinduced by TNF-α. Furthermore, a significant increase in FSTL1 levels was observed in adipose tissue of obese ob/ob mice, as well as in serum of overweight/obese subjects. Mechanistic studies revealed that FSTL1 induced inflammatory responses in both 3T3-L1 adipocytes and RAW264.7 macrophages. The expression of proinflammatory mediators including IL-6, TNF-α, and MCP-1 was upregulated by recombinant FSTL1 in a dose-dependent manner, paralleled with activation of the IKKß-NFκB and JNK signaling pathways in the two cell lines. Moreover, FSTL1 impaired insulin signaling in 3T3-L1 adipocytes, as revealed by attenuated phosphorylation of both Akt and IRS-1 in response to insulin stimulation. Together, our results suggest that FSTL1 is a potential mediator of inflammation and insulin resistance in obesity.


Subject(s)
Follistatin-Related Proteins/physiology , Inflammation/etiology , Obesity/complications , 3T3-L1 Cells , Adipocytes/cytology , Adipocytes/immunology , Adipose Tissue/metabolism , Animals , Cell Differentiation , Follistatin-Related Proteins/analysis , Humans , I-kappa B Kinase/physiology , Inflammation Mediators/metabolism , Insulin/pharmacology , Insulin Resistance , Macrophages/immunology , Male , Mice , Mice, Inbred C57BL , NF-kappa B/physiology , Signal Transduction , Toll-Like Receptor 4/physiology , Tumor Necrosis Factor-alpha/pharmacology
5.
Clin Chim Acta ; 413(5-6): 533-6, 2012 Mar 22.
Article in English | MEDLINE | ID: mdl-22122995

ABSTRACT

BACKGROUND: The objective of this study was to determine maternal and placental concentrations of follistatin-like 3 (FSTL3), and, maternal concentrations of myostatin in gestational diabetes mellitus (GDM). METHODS: 40 women with GDM of term pregnancy were recruited and 40 maternal age- and gestational age-matched normally pregnant women served as control. Maternal blood samples and placental tissues were collected. Maternal concentrations of FSTL3 and myostatin were determined by enzyme-linked immunosorbent assay (ELISA), and, placental concentrations of FSTL3 by Western blotting. RESULTS: Women with GDM had significantly lower serum FSTL3 concentrations than controls (P=0.001). Placental concentrations of FSTL3 were significantly lower in GDM group than in controls (P<0.001). Women with GDM had significantly higher homeostasis model assessment of insulin resistance (HOMA-IR) and glycosylated hemoglobin (HbAlc) than control women (P=0.042 and <0.01, respectively). Maternal serum myostatin was not significantly different between GDM and control groups (P=0.312). CONCLUSIONS: Maternal and placental FSTL3 concentrations were reduced in GDM women compared with normally pregnant women, suggesting FSTL3 may play an important role in the pathogenesis of gestational diabetes.


Subject(s)
Diabetes, Gestational/blood , Diabetes, Gestational/metabolism , Follistatin-Related Proteins/analysis , Placenta/metabolism , Pregnancy Complications/blood , Pregnancy Complications/metabolism , Adult , Case-Control Studies , Female , Follistatin-Related Proteins/blood , Humans , Pregnancy
7.
Arthritis Res Ther ; 13(1): R17, 2011 Feb 08.
Article in English | MEDLINE | ID: mdl-21303509

ABSTRACT

INTRODUCTION: Follistatin-like protein 1 (FSTL1) is a proinflammation mediator implicated in arthritis in rodent animal models. The present study is aimed at assessing FSTL1 levels in systemic autoimmune diseases and correlating them with disease activity in patients with rheumatoid arthritis (RA). METHODS: Serum FSTL1 levels from 487 patients with systemic autoimmune diseases and 69 healthy individuals were measured by enzyme-linked immunosorbent assay (ELISA). FSTL1 expression in synovial fluid (SF) and synovial tissues (STs) was determined by ELISA, immunohistochemistry, real-time polymerase chain reaction (RT-PCR) and western blot analysis in RA patients and trauma controls. FSTL1 levels in fibroblast-like synoviocytes (FLSs) from RA patients were determined by real-time PCR and western blot analysis. RESULTS: Serum FSTL1 levels were significantly elevated in patients with RA, ulcerative colitis, systemic lupus erythematosus, Sjögren's syndrome (SS), systemic sclerosis and polymyositis/dermatomyositis. Serum FSTL1 levels in the RA and secondary SS patients were substantially higher than those in other patients. Serum FSTL1 levels were increased in early RA, rheumatoid factor (RF)- and anti-cyclic citrullinated peptide antibody (ACPA)-negative patients compared to healthy controls. Moreover, serum FSTL1 concentrations were significantly higher in long-standing RA patients than in early RA patients and in the RF- and ACPA-positive RA patients than in RF- and ACPA-negative RA patients. Elevated FSTL1 levels in the STs and SF of RA patients were also observed. FSTL1 levels in serum were markedly higher than those in SF in RA patients. The strongest FSTL1 staining was detected in the cytoplasm of synovial and capillary endothelial cells from RA synovium. Furthermore, FSTL1 was induced in FLSs by inflammatory mediators. Importantly, serum FSTL1 levels were correlated with several important biologic and clinical markers of disease activity, including erythrocyte sedimentation rate, C-reactive protein, RF, ACPA, swollen joint count, patient global visual analogue scale score and Disease Activity Score 28 in the adult RA patient population. Notably, serum FSTL1 levels were significantly diminished following successful treatment and clinical improvement. CONCLUSIONS: Elevated FSTL1 levels reflect not only joint diseases but also inflammation and tissue degradation in systemic autoimmune diseases. Serum FSTL1 levels may thus serve as a serological inflammatory marker of disease activity in RA patients.


Subject(s)
Arthritis, Rheumatoid/immunology , Biomarkers/analysis , Follistatin-Related Proteins/immunology , Adult , Arthritis, Rheumatoid/metabolism , Autoimmune Diseases/immunology , Autoimmune Diseases/metabolism , Biomarkers/metabolism , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Fibroblasts/immunology , Fibroblasts/metabolism , Follistatin-Related Proteins/analysis , Follistatin-Related Proteins/metabolism , Humans , Immunohistochemistry , Middle Aged , Real-Time Polymerase Chain Reaction , Young Adult
8.
Placenta ; 29(1): 51-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17959243

ABSTRACT

Hypoxic injury hinders placental differentiation and alters trophoblast gene expression. We tested the hypothesis that the expression of follistatin-like 3 (FSTL3), a member of the follistatin family of proteins, is modulated by hypoxia in primary human trophoblast (PHT). Using immunofluorescence of human term placental villi we detected the expression of FSTL3 protein in placental villi, primarily in trophoblasts. We verified this finding in cultured term PHT cells. Basal expression of FSTL3 transcript in cultured PHT cells, determined using quantitative PCR, was stable over the culture period. Importantly, when compared to culture in FiO(2)=20% or FiO(2)=8%, PHT cells cultured in FiO(2) <1% exhibited a 4-6 fold increase in FSTL3 mRNA expression as early as 4h in hypoxia. Whereas cellular FSTL3 protein was unchanged in hypoxia, we found that hypoxia increased the level of FSTL3 in the medium. Lastly, the exposure of PHT cells to either the hypoxia-mimetic cobalt chloride or the proline hydroxylase inhibitor dimethyloxaloylglycine upregulated the expression of FSTL3 transcript. Our data indicate that hypoxia enhances the expression of FSTL3 and its release from PHT cells. Our finding that hypoxia-mimetic agents enhance FSTL3 expression implicates HIF1alpha in this process.


Subject(s)
Follistatin-Related Proteins/metabolism , Hypoxia/metabolism , Trophoblasts/metabolism , Female , Follistatin-Related Proteins/analysis , Follistatin-Related Proteins/genetics , Humans , Hypoxia/genetics , Pregnancy , RNA, Messenger/analysis , RNA, Messenger/metabolism , Term Birth , Trophoblasts/chemistry
9.
Mol Cell Endocrinol ; 225(1-2): 1-8, 2004 Oct 15.
Article in English | MEDLINE | ID: mdl-15451561

ABSTRACT

Activin type II receptors (ActRIIs) are the primary receptors that transmit the activin signal to intracellular signaling pathways. Binding of activins to ActRIIs recruits the activin type I receptor and initiates downstream signaling. We have found that PDZ proteins, named activin receptor-interacting proteins (ARIPs), specifically associate with ActRIIs. We have studied the mechanism that ARIPs regulate cell surface expression and cellular localization of ActRIIs. ARIP2 interacts with both ActRIIs and RalBP1 (Ral binding protein 1) through different domains to dramatically change the localization of ActRIIs. Overexpression of ARIP2 enhances endocytosis of ActRIIs. These data indicate that ARIP2 is a novel factor regulating cell surface ActRII expression and activin function. A novel activin binding protein, follistatin-related gene (FLRG) was identified. FLRG protein binds activin and myostatin with a high affinity. The biological activity of FLRG is similar to those of follistatin, however, the regulation and expression patterns of follistatin and FLRG differ. Immunohistochemical analysis shows that FLRG is distributed in spermatogenic cells of the testis, renal tubules, epithelial cells of the lung, and myocardium. Thus, although structurally and functionally similar, follistatin and FLRG likely play distinct roles as activin/GDF binding proteins in vivo.


Subject(s)
Activin Receptors, Type II/metabolism , Activins/metabolism , Adaptor Proteins, Signal Transducing/physiology , Follistatin-Related Proteins/metabolism , Membrane Proteins/physiology , Signal Transduction , Activin Receptors, Type II/genetics , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Animals , Brain Chemistry , CHO Cells , Cricetinae , Endocytosis , Follistatin/analysis , Follistatin/genetics , Follistatin-Related Proteins/analysis , Follistatin-Related Proteins/genetics , Immunohistochemistry , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , RNA, Messenger/analysis , Tissue Distribution , Transfection , Two-Hybrid System Techniques
10.
J Comp Neurol ; 473(4): 496-510, 2004 Jun 07.
Article in English | MEDLINE | ID: mdl-15116386

ABSTRACT

The functions of Wingless-Int (Wnt) signaling, studied intensely in embryonic brain development, have been comparatively little investigated in the postnatal brain. We report remarkably patterned gene expression of Wnt signaling components in postnatal mouse cerebral cortex, lasting into young adulthood. Wnt genes are expressed in gene-specific regional and lamina patterns in each of the major subdivisions of the cerebral cortex: the olfactory bulb (OB), the hippocampal formation, and the neocortex. Genes encoding Frizzled (Fz) Wnt receptors, or secreted Frizzled-related proteins (sFrps), are also expressed in regional and lamina patterns. These findings suggest that Wnt signaling is active and regulated in the postnatal cortex and that different cortical cell populations have varying requirements for a Wnt signal. The OB, in particular, shows gene expression of a large variety of Wnt signaling components, making it a prime target for future functional studies. The penultimate components of the canonical Wnt pathway are the Tcf/Lef1 transcription factors, which regulate transcription of Wnt signaling target genes. Surprisingly, we found little Tcf/Lef1 expression in the postnatal neocortex. These observations suggest that noncanonical Wnt pathways predominate, which will require functional testing. However, Lef1 is widely expressed in the dorsal thalamus, and Wnt ligands and receptors are expressed, respectively, in cortical areas and thalamic nuclei that are interconnected. Thus, canonical Wnt signaling could be utilized in a major cortical input by Fz- and Lef1-expressing thalamic cells that innervate the Wnt-expressing cortex.


Subject(s)
Cerebral Cortex/metabolism , Follistatin-Related Proteins/genetics , Gene Expression Regulation, Developmental/physiology , Proteins/genetics , Proto-Oncogene Proteins/genetics , Zebrafish Proteins , Animals , Animals, Newborn , Cerebral Cortex/chemistry , Cerebral Cortex/growth & development , Follistatin-Related Proteins/analysis , Follistatin-Related Proteins/biosynthesis , Frizzled Receptors , Mice , Protein Biosynthesis , Proteins/analysis , Proto-Oncogene Proteins/analysis , Proto-Oncogene Proteins/biosynthesis , Wnt Proteins
11.
Neurosci Lett ; 346(1-2): 105-8, 2003 Jul 31.
Article in English | MEDLINE | ID: mdl-12850559

ABSTRACT

The gene occ1 is preferentially expressed in the primary visual cortex in an activity-dependent and developmentally regulated manner. In this report, we show the characteristic distribution of occ1 transcripts in the CA2 subfield of the hippocampal formation in adult monkeys. occ1 mRNA signals were observed selectively in the pyramidal cell layer of CA2. In addition to these signals, a relatively sparse distribution of occ1 was found in the stratum oriens and, occasionally, in the outermost regions of the pyramidal cell layers of both CA1 and CA2. A few labeled cells were detected in CA3. The elevated expression of occ1 in the CA2 subfield provides a new approach for investigating the function of this subregion, whose role has still not been well clarified.


Subject(s)
Follistatin-Related Proteins/biosynthesis , Gene Expression Regulation/physiology , Hippocampus/metabolism , RNA, Messenger/biosynthesis , Animals , Follistatin-Related Proteins/analysis , Hippocampus/chemistry , Macaca , RNA, Messenger/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...